205 related articles for article (PubMed ID: 28247189)
1. Successful treatment of histiocytic sarcoma with cladribine and high-dose cytosine arabinoside in a child.
Iwabuchi H; Kawashima H; Umezu H; Takachi T; Imamura M; Saitoh A; Ogose A; Imai C
Int J Hematol; 2017 Aug; 106(2):299-303. PubMed ID: 28247189
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy.
Heath JL; Burgett SE; Gaca AM; Jaffe R; Wechsler DS
Pediatr Blood Cancer; 2014 Oct; 61(10):1874-6. PubMed ID: 24888336
[TBL] [Abstract][Full Text] [Related]
3. Salvage of relapsed malignant histiocytosis by autologous bone marrow transplant.
Berry J; Russell JA
Bone Marrow Transplant; 1989 Jan; 4(1):123-4. PubMed ID: 2466511
[TBL] [Abstract][Full Text] [Related]
4. Primary Orbital Histiocytic Sarcoma in a Child Successfully Treated With Multiagent Chemotherapy.
Mittal N; Aakalu V; Mehendele S; Setabutr P; Michals E; Schmidt ML
J Pediatr Hematol Oncol; 2016 Nov; 38(8):653-657. PubMed ID: 27467374
[TBL] [Abstract][Full Text] [Related]
5. Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group.
Wierzbowska A; Robak T; Pluta A; Wawrzyniak E; Cebula B; Hołowiecki J; Kyrcz-Krzemień S; Grosicki S; Giebel S; Skotnicki AB; Piatkowska-Jakubas B; Kuliczkowski K; Kiełbiński M; Zawilska K; Kłoczko J; Wrzesień-Kuś A;
Eur J Haematol; 2008 Feb; 80(2):115-26. PubMed ID: 18076637
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group.
Wrzesień-Kuś A; Robak T; Wierzbowska A; Lech-Marańda E; Pluta A; Wawrzyniak E; Krawczyńska A; Kuliczkowski K; Mazur G; Kiebiński M; Dmoszyńska A; Wach M; Hellmann A; Baran W; Hołowiecki J; Kyrcz-Krzemień S; Grosicki S;
Ann Hematol; 2005 Sep; 84(9):557-64. PubMed ID: 15856358
[TBL] [Abstract][Full Text] [Related]
7. Retroperitoneal Bulky Histiocytic Sarcoma Successfully Treated with Induction Chemotherapy Followed by Curative Surgery.
Oto M; Maeda A; Nose T; Ueda Y; Uneda S; Inadome A; Oshima K; Yoshida M
Intern Med; 2017 Oct; 56(20):2765-2768. PubMed ID: 28924109
[TBL] [Abstract][Full Text] [Related]
8. A case of spindle cell dominant histiocytic sarcoma showing a complete remission after first-line chemotherapy with doxorubicin and ifosfamide.
Nakamura Y; Takemasa A; Kushima Y; Soda S; Ikeda N; Arai R; Chibana K; Nakazato Y; Yokose T; Shimizu Y; Niho S
J Chemother; 2020 Dec; 32(8):445-450. PubMed ID: 32431236
[TBL] [Abstract][Full Text] [Related]
9. Langerhans cell sarcoma of the nasopharynx: a rare case.
Keklik M; Sivgin S; Kontas O; Abdulrezzak U; Kaynar L; Cetin M
Scott Med J; 2013 Nov; 58(4):e17-20. PubMed ID: 24215052
[TBL] [Abstract][Full Text] [Related]
10. Treatment of refractory Langerhans cell histiocytosis (LCH) with a combination of 2-chlorodeoxyadenosine and cytosine arabinoside.
Apollonsky N; Lipton JM
J Pediatr Hematol Oncol; 2009 Jan; 31(1):53-6. PubMed ID: 19125089
[TBL] [Abstract][Full Text] [Related]
11. A Rare Case of Primary Histiocytic Sarcoma of the Stomach.
Petkova NY; Hristoskova RG; Guenova ML; Raynov JI
Folia Med (Plovdiv); 2018 Jun; 60(2):318-322. PubMed ID: 30355826
[TBL] [Abstract][Full Text] [Related]
12. Leukemic Phase of Histiocytic Sarcoma of the Digestive System: A Rare Manifestation of a Rare Disease.
Hofstetter L; Aranovich D; Bernstine H; Hayman L; Shahal-Zimra Y; Rabizadeh E; Cohen A; Lahav M; Raanani P; Wolach O
Acta Haematol; 2021; 144(2):229-235. PubMed ID: 33017829
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
Abali H; Urün Y; Oksüzoğlu B; Budakoğlu B; Yildirim N; Güler T; Ozet G; Zengin N
Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
[TBL] [Abstract][Full Text] [Related]
14. A patient with regressing atypical histiocytosis running a far from benign course.
Morgan JS; Levay J
Clin Oncol (R Coll Radiol); 1993; 5(5):323-4. PubMed ID: 8305346
[TBL] [Abstract][Full Text] [Related]
15. Reduced doses of cladribine and cytarabine regimen was effective and well tolerated in patients with refractory-risk multisystem Langerhans cell histiocytosis.
Rosso DA; Amaral D; Latella A; Chantada G; Braier JL
Br J Haematol; 2016 Jan; 172(2):287-90. PubMed ID: 25944303
[No Abstract] [Full Text] [Related]
16. Comparison of cladribine- and fludarabine-based induction chemotherapy in relapsed or refractory acute myeloid leukaemia.
Park H; Youk J; Kim I; Yoon SS; Park S; Lee JO; Bang SM; Koh Y
Ann Hematol; 2016 Oct; 95(11):1777-86. PubMed ID: 27539617
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Toxicity of Induction Therapy with Cladribine, Idarubicin, and Cytarabine (IAC) for Acute Myeloid Leukemia.
Woelich SK; Braun JT; Schoen MW; Ramlal R; Freter CE; Petruska PJ; Lionberger JM
Anticancer Res; 2017 Feb; 37(2):713-717. PubMed ID: 28179321
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of histiocytic sarcoma and concurrent HIV infection using a combination of CHOP and antiretroviral therapy.
Narita K; Noro R; Seike M; Matsumoto M; Fujita K; Matsumura J; Takahashi M; Kawamoto M; Gemma A
Intern Med; 2013; 52(24):2805-9. PubMed ID: 24334590
[TBL] [Abstract][Full Text] [Related]
19. Histiocytic sarcoma of the thyroid.
Munoz J; Sanchez BE; Wang D
Am J Hematol; 2012 May; 87(5):531. PubMed ID: 22121014
[No Abstract] [Full Text] [Related]
20. High-dose methotrexate-based chemotherapy as treatment for histiocytic sarcoma of the central nervous system.
Curry RC; Faivre G; Akkari L; Joyce JA; Lin O; Rosenblum M; Diamond EL; Fisher R; Omuro A
Leuk Lymphoma; 2016 Aug; 57(8):1961-4. PubMed ID: 26727454
[No Abstract] [Full Text] [Related]
[Next] [New Search]
